Furthermore, western blotting revealed that suppressing mTOR expression inhibits the progression of EMT in pancreatic cancer by downregulating the expression of N-cadherin and Vimentin but upregulating the expression of E-cadherin (Fig. 5C, D and Supplementary Figs. S11A–J). Here, CDH2 is linked to pancreatic neoplasm.